SCHEMBL23309657

SCHEMBL23309657

COc1ccccc1OC(=O)c1cc(F)nc(F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ PRSS1 P07477 1/20 0.51
▸ ACR P10323 1/20 0.51
▸ MAPT P10636 3/20 0.50
▸ SERPINE1 P05121 1/20 0.50
▸ ALDH1A1 P00352 3/20 0.49
▸ POLB P06746 1/20 0.49
▸ KMT2A Q03164 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ CYP3A4 P08684 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ SLC6A3 Q01959 1/20 0.43
▸ LMNA P02545 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309563 0.84 POLB (0.47) TSHRSMN1; SMN2MAPTSERPINE1POLB
SCHEMBL23309741 0.84 SERPINE1 (0.53) TSHRSMN1; SMN2MAPTSERPINE1ALDH1A1
SCHEMBL23309626 0.81 NPSR1 (0.47) TSHRSMN1; SMN2MAPTSERPINE1ALDH1A1
SCHEMBL23309684 0.80 ALOX5 (0.60) SMN1; SMN2MAPTSERPINE1ALDH1A1POLB
SCHEMBL23309596 0.80 MAPT (0.51) TSHRSMN1; SMN2PRSS1ACRMAPT
SCHEMBL12520418 0.79 PRSS1 (0.73) TSHRSMN1; SMN2PRSS1ACRMAPT
SCHEMBL18341496 0.79 SERPINE1 (0.64) TSHRSMN1; SMN2PRSS1ACRMAPT
SCHEMBL1671519 0.78 PRSS1 (0.66) TSHRSMN1; SMN2PRSS1ACRMAPT
SCHEMBL29749397 0.78 PRSS1 (0.66) TSHRSMN1; SMN2PRSS1ACRMAPT
SCHEMBL4737505 0.78 SERPINE1 (0.83) TSHRSMN1; SMN2PRSS1ACRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL TSHR 4374/4885SMN1; SMN2 3893/4885PRSS1 2309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback